Voyager Therapeutics Inc (VYGR)
7.62
+0.20
(+2.70%)
USD |
NASDAQ |
Apr 26, 16:00
7.62
0.00 (0.00%)
Pre-Market: 20:00
Voyager Therapeutics Revenue (TTM): 250.01M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 250.01M |
| September 30, 2023 | 158.40M |
| June 30, 2023 | 194.87M |
| March 31, 2023 | 190.73M |
| December 31, 2022 | 40.91M |
| September 30, 2022 | 70.53M |
| June 30, 2022 | 30.92M |
| March 31, 2022 | 31.57M |
| December 31, 2021 | 37.41M |
| September 30, 2021 | 15.88M |
| June 30, 2021 | 132.24M |
| March 31, 2021 | 159.56M |
| December 31, 2020 | 171.13M |
| September 30, 2020 | 197.26M |
| June 30, 2020 | 99.86M |
| March 31, 2020 | 117.26M |
| December 31, 2019 | 104.39M |
| Date | Value |
|---|---|
| September 30, 2019 | 73.72M |
| June 30, 2019 | 55.39M |
| March 31, 2019 | 11.87M |
| December 31, 2018 | 7.619M |
| September 30, 2018 | 11.96M |
| June 30, 2018 | 11.01M |
| March 31, 2018 | 9.612M |
| December 31, 2017 | 10.13M |
| September 30, 2017 | 6.151M |
| June 30, 2017 | 8.311M |
| March 31, 2017 | 10.85M |
| December 31, 2016 | 14.22M |
| September 30, 2016 | 16.80M |
| June 30, 2016 | 18.42M |
| March 31, 2016 | 19.59M |
| December 31, 2015 | 17.33M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
15.88M
Minimum
Sep 2021
250.01M
Maximum
Dec 2023
112.21M
Average
104.39M
Median
Dec 2019
Revenue (TTM) Benchmarks
| Biogen Inc | 9.663B |
| United Therapeutics Corp | 2.328B |
| MEI Pharma Inc | -- |
| Macrogenics Inc | 56.91M |
| Moderna Inc | 6.754B |